Table 1.
Clinical characteristics of ovarian cancer cases included in this study.
| Clinical Characteristic | Low HDAC6 | High HDAC6 | Overall |
|---|---|---|---|
| n = 23 (%) | n = 23 (%) | n = 46 (%) | |
| Age (years) | |||
| Mean | 54 | 60 | 57 |
| Median | 54 | 61 | 59 |
| Standard Deviation | 9 | 10 | 10 |
| Range | 41–74 | 36–76 | 36–76 |
| FIGO Stage | |||
| I/II | 1 (4.3%) | 5 (27.7%) | 6 (13%) |
| III/IV | 22 (95.7%) | 18 (78.3%) | 40 (87%) |
| Grade | |||
| Unknown | 1 (4.3%) | 1 (4.3%) | 2 (4.3%) |
| Low | 1 (4.3%) | 0 (0%) | 1 (2.2%) |
| Intermediate | 8 (34.9%) | 6 (26.1%) | 14 (30.5%) |
| High | 13 (56.5%) | 16 (69.6%) | 29 (63%) |
| Cytoreduction/Cytoreductive surgery | |||
| Unknown | 2 (8.7%) | 0 (0%) | 2 (4.3%) |
| sub-Optimal > 1 | 3 (13%) | 7 (30.4%) | 10 (21.8%) |
| Optimal ≤ 1 | 18 (78.3%) | 16 (69.6%) | 34 (73.9%) |